Wooree Bio Co.,Ltd (KOSDAQ: 082850)

Wooree Bio Co.,Ltd Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating Revenue	1,303,982	1,263,944	1,355,056	1,543,312	1,623,383	1,672,648
Other Revenue	-0	-0	-	-	0	-0
Revenue	1,303,982	1,263,944	1,355,056	1,543,312	1,623,383	1,672,648
Revenue Growth (YoY)	11.58%	-6.72%	-12.20%	-4.93%	-2.95%	30.71%
Cost of Revenue	1,176,852	1,148,606	1,241,417	1,427,899	1,523,846	1,584,450
Gross Profit	127,130	115,337	113,639	115,412	99,537	88,198
Selling, General & Admin	81,266	74,363	65,396	57,472	47,617	48,471
Research & Development	9,011	8,398	7,019	7,382	6,631	6,566
Other Operating Expenses	1,318	1,350	1,884	1,274	1,376	1,550
Operating Expenses	96,725	89,355	79,398	72,995	62,095	63,873
Operating Income	30,404	25,982	34,241	42,417	37,442	24,325
Interest Expense	-5,632	-6,052	-4,948	-4,438	-6,468	-9,139
Interest & Investment Income	4,268	3,834	1,632	427.15	320.28	397.14
Earnings From Equity Investments	-178.7	-190.83	-123.76	-184.23	13.08	-1,316
Currency Exchange Gain (Loss)	234.33	-1,908	-116.95	4,510	-2,077	282.09
Other Non Operating Income (Expenses)	0.36	250.77	1,224	2,566	3,930	-2,666
EBT Excluding Unusual Items	29,096	21,917	31,909	45,298	33,161	11,883
Gain (Loss) on Sale of Investments	-	-	-	188.71	-1,865	-169.56
Gain (Loss) on Sale of Assets	132.1	-187.34	117.01	-206.37	-9,019	-41.51
Asset Writedown	-1,811	-	-	-	-52.45	-1,337
Other Unusual Items	-	-	-	-	-	62.76
Pretax Income	27,418	21,729	32,026	45,281	22,224	10,397
Income Tax Expense	4,712	2,783	6,900	1,239	5,241	4,301
Earnings From Continuing Operations	22,705	18,946	25,126	44,041	16,983	6,096
Net Income to Company	22,705	18,946	25,126	44,041	16,983	6,096
Minority Interest in Earnings	-6,839	-3,365	-3,304	-10,886	-141.65	-1,565
Net Income	15,866	15,581	21,822	33,156	16,841	4,532
Net Income to Common	15,866	15,581	21,822	33,156	16,841	4,532
Net Income Growth	52.50%	-28.60%	-34.18%	96.87%	271.64%	-
Shares Outstanding (Basic)	47	47	46	44	44	42
Shares Outstanding (Diluted)	48	47	46	48	45	45
Shares Change (YoY)	-0.02%	1.95%	-2.87%	5.70%	-	12.46%
EPS (Basic)	337.01	330.98	469.36	750.13	385.66	107.04
EPS (Diluted)	333.85	329.00	469.00	702.06	376.03	106.35
EPS Growth	56.22%	-29.85%	-33.20%	86.70%	253.57%	-
Free Cash Flow	26,482	16,018	30,085	38,588	52,167	41,688
Free Cash Flow Per Share	557.18	337.94	647.10	806.13	1151.92	920.53
Gross Margin	9.75%	9.13%	8.39%	7.48%	6.13%	5.27%
Operating Margin	2.33%	2.06%	2.53%	2.75%	2.31%	1.45%
Profit Margin	1.22%	1.23%	1.61%	2.15%	1.04%	0.27%
Free Cash Flow Margin	2.03%	1.27%	2.22%	2.50%	3.21%	2.49%
EBITDA	60,030	57,832	70,435	77,974	76,287	64,376
EBITDA Margin	4.60%	4.58%	5.20%	5.05%	4.70%	3.85%
D&A For EBITDA	29,625	31,850	36,194	35,557	38,845	40,051
EBIT	30,404	25,982	34,241	42,417	37,442	24,325
EBIT Margin	2.33%	2.06%	2.53%	2.75%	2.31%	1.45%
Effective Tax Rate	17.19%	12.81%	21.54%	2.74%	23.58%	41.37%
Advertising Expenses	-	9,177	8,633	3,642	246.06	64.8

Source: S&P Capital IQ. Standard template. Financial Sources.